Search the Newsreel

Pine Cliff sold gas at a 47% premium to the AECO price

International Flavors & Fragrances Inc. stock underperforms Wednesday when compared to competitors

International Flavors & Fragrances Inc. (IFF) stock dropped 1.35% to $83.85 on Wednesday, marking its third consecutive day of losses. This underperformance occurred during a mixed trading session where the S&P 500 Index saw a slight gain, while the Dow Jones Industrial Average experienced …

Is Cleveland-Cliffs (NYSE:CLF) In Focus As Infrastructure Demand Lifts Steel?

Cleveland-Cliffs (NYSE:CLF) is gaining attention as an integrated iron ore and steel producer, prominent due to the rising demand from infrastructure and automotive sectors. The company's unique position in the domestic market, spanning from raw material extraction to finished steel products, makes it a …

Earnings Flash (BIR.TO) Birchcliff Energy Ltd. Posts Q2 Adjusted EPS C$0.34 per Share

Birchcliff Energy Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Griffon (GFF) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, August 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Ronald KramerChief Financial Officer - Brian Harris Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAWAYS Revenue -- $481.4 million, …

Cardiff Loss Narrows In Q2; Directs Resources To Phase 3 For Onvansertib In Q1 '27

(RTTNews) - Cardiff Oncology, Inc. (CRDF) a clinical-stage oncology company, reported second quarter results, reflecting a narrower loss primarily driven by lower operating expenses. The company in particular noted reduced Research and Development (R&D) expenses following the completion of clinical trials and lesser preclinical …

William Blair Downgrades Cardiff Oncology to Market Perform From Outperform

William Blair has downgraded Cardiff Oncology (CRDF) from an "Outperform" rating to "Market Perform." This comes shortly after Cardiff Oncology reported its earnings results for the second quarter and six months ended June 30, 2026. The company is a clinical-stage biotechnology firm focused on …

Quantinno Capital Management LP Buys 86,036 Shares of Cleveland-Cliffs Inc. $CLF

Quantinno Capital Management LP significantly increased its stake in Cleveland-Cliffs Inc. by 68% in the first quarter, acquiring an additional 86,036 shares, bringing their total holdings to 212,522 shares valued at approximately $1.8 million. Other institutional investors like Vanguard, State Street, Castle Hook Partners, …

William Blair downgrades Cardiff Oncology stock rating on rights uncertainty

William Blair has downgraded Cardiff Oncology (NASDAQ: CRDF) from Outperform to Market Perform, citing material deterioration in company fundamentals and uncertainty surrounding onvansertib rights. This downgrade follows Cardiff’s Q2 financial results and business update, with the stock already down 63% year-to-date and the company …

The 5 Most Interesting Analyst Questions From Griffon’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Griffon's Q2 Earnings Call Griffon's second quarter was marked by strong execution despite a 21.6% year-over-year decline in sales, as the company outperformed Wall Street's expectations on both revenue and non-GAAP earnings per share. The market responded …

Ziff Davis EVP Rossen disposes of $209,777 in company stock

Jeremy Rossen, EVP and General Counsel at Ziff Davis (NASDAQ:ZD), sold 3,819 shares worth approximately $209,777 on August 10, 2026, retaining a direct holding of 10,643 shares and indirect ownership of 2,000 shares through a family trust. The company, trading near its 52-week high …

Cardiff Oncology (NASDAQ: CRDF) cuts R&D spend but flags going concern risk

Cardiff Oncology reported a Q2 2026 net loss of $9.2 million and a six-month operating cash outflow of $24.1 million, reducing R&D expenses by cutting clinical trials and preclinical work. The company raised $10.1 million in a direct offering but issued a "going concern" …

Jeremy Rossen Sells 3,819 Shares of Ziff Davis (NASDAQ:ZD) Stock

Ziff Davis (NASDAQ: ZD) EVP and General Counsel sells 3,819 shares

Jeremy Rossen, EVP and General Counsel of Ziff Davis (NASDAQ: ZD), sold 3,819 shares of common stock on August 10, 2026, at an average price of $54.93 per share. Following the sale, he directly holds 10,643 shares and indirectly holds 2,000 shares through a …

Griffon (NYSE:GFF) COO Sells $692,713.26 in Stock

Griffon COO Robert Mehmel sold 6,639 shares of company stock for $692,713.26 on August 10th, under a pre-arranged Rule 10b5-1 plan, while still retaining over 726,000 shares. The sale occurred as Griffon's shares traded near their 12-month high, following the company's Q2 earnings beat …

Cardiff Oncology earnings missed by $0.02, revenue topped estimates

Cardiff Oncology: Q2 Earnings Snapshot

Cardiff Oncology, Inc. (CRDF) reported a Q2 loss of $9.2 million, or 14 cents per share, surpassing Wall Street expectations that predicted a loss of 17 cents per share. The company achieved revenue of $104,000, which met Street forecasts. This financial summary was generated …

Cardiff Oncology (NASDAQ:CRDF) Releases Earnings Results, Misses Expectations By $0.02 EPS

Cardiff Oncology (NASDAQ:CRDF) reported a quarterly loss of $0.14 per share, missing analyst expectations by $0.02, despite revenue of $0.10 million surpassing the consensus estimate. The company's shares are trading under pressure, well below moving averages, and analysts generally hold a "Hold" rating. Despite …

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Cardiff Oncology announced its second quarter 2026 financial results and provided a business update, highlighting positive Phase 2 data for its drug onvansertib in first-line RAS-mutated metastatic colorectal cancer. The company plans to initiate a registrational Phase 3 trial in Q1 2027, pending additional …

Griffon Corporation (GFF) prices $800M 6.25% notes to redeem 2028 debt

Griffon Corporation announced the pricing of $800 million aggregate principal amount of 6.25% senior notes due 2034 in a private offering. The company intends to use the net proceeds from these new notes, along with cash on hand and revolver borrowings, to redeem all …

Birchcliff Energy (TSX:BIR) Could Be 47% Undervalued After Board Appointment

This Insider Has Just Sold Shares In Griffon

Ronald Kramer, Chairman and CEO of Griffon Corporation, recently sold US$10 million worth of shares, representing 5.5% of his holding. While this was the largest insider sale in the past year, the company's insiders sold more than they bought overall. Despite this, Griffon is …

Diffusion Engineers Q1FY27 consolidated PAT rises 36% on revenue surge

Why Northcliff Resources Ltd stock fell yesterday

Ziff Davis: Cash Surges To $1.61 Billion After $1.22 Billion Connectivity Sale As Buybacks Accelerate

Ziff Davis's cash reserves significantly increased to $1.61 billion after the $1.22 billion sale of its Connectivity business. This influx of capital positions the company for strategic deployment into acquisitions and accelerated share repurchases, with $121.5 million already spent on buybacks in Q2. Despite …

Diffusion Engineers Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Diffusion Engineers consolidated net profit rises 36.26% in the June 2026 quarter

Diffusion Engineers Q1 Results: Standalone profit falls 30% YoY

Diffusion Engineers consolidated profit rises 36%, standalone falls 30% in Q1FY26

Ziff Davis, Inc. (NASDAQ:ZD) Given Consensus Rating of "Hold" by Analysts

Ziff Davis, Inc. (NASDAQ:ZD) has received a consensus "Hold" rating from nine analysts, with five recommending hold, three buy, and one sell. The average 12-month price target is $53.00, slightly below its opening price of $54.31. The company recently reported adjusted EPS of $1.03, …

Ziff Davis Inc (ZD) Earnings Forecast: Future EPS & Revenue Growth Estimates

International Flavors & Fragrances Inc. (NYSE:IFF) Given Consensus Recommendation of "Moderate Buy" by Brokerages

International Flavors & Fragrances Inc. (NYSE:IFF) has received a consensus "Moderate Buy" recommendation from twenty brokerages, with an average 12-month price target of $92.16. Despite missing quarterly earnings and revenue estimates, the company's shares opened near their 52-week high, and it has declared a …

Will Birchcliff Energy Ltd. (BIR) Beat Earnings Estimates in Its Next Report?

Griffon prices $800 million senior notes due 2034 at 6.25%

Griffon Corporation has priced $800 million in senior notes due 2034 with an interest rate of 6.25% per annum. The private placement is expected to close on August 18, 2026. Proceeds from this offering, along with existing cash and credit facilities, will be used …

Griffon Sets 6.25% Rate on Notes to Redeem $975M Debt

Griffon Corporation announced the pricing of an $800 million aggregate principal amount of senior notes due 2034 with a 6.25% interest rate. The proceeds from this private placement, along with cash on hand and revolver borrowings, will be used to redeem Griffon's outstanding $975 …